Harry A. Rogoff

1.4k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Harry A. Rogoff is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Harry A. Rogoff has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Harry A. Rogoff's work include Cancer-related Molecular Pathways (6 papers), Cancer Cells and Metastasis (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Harry A. Rogoff is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Cancer Cells and Metastasis (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Harry A. Rogoff collaborates with scholars based in United States, Spain and Sweden. Harry A. Rogoff's co-authors include Chiang J. Li, Timothy F. Kowalik, Mary Pickering, Manish A. Shah, Wěi Li, Xiangao Sun, Youzhi Li, David Leggett, Sarah Keates and Yuan Gao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Nature Biotechnology.

In The Last Decade

Harry A. Rogoff

21 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of cancer relapse and metastasis by inhibiting cancer stemness

2015 382 citations Youzhi Li, Harry A. Rogoff et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harry A. Rogoff United States	13	746	525	243	108	106	21	1.1k
DB Longley United Kingdom	2	778 1.0×	552 1.1×	285 1.2×	49 0.5×	27 0.3×	3	1.3k
Weidan Ji China	19	945 1.3×	252 0.5×	519 2.1×	97 0.9×	34 0.3×	32	1.3k
Sukesh Voruganti United States	17	593 0.8×	326 0.6×	167 0.7×	63 0.6×	45 0.4×	21	862
Zizheng Dong United States	25	1.2k 1.6×	488 0.9×	348 1.4×	66 0.6×	26 0.2×	49	1.6k
Jichuang Wang China	24	692 0.9×	412 0.8×	198 0.8×	39 0.4×	35 0.3×	42	1.2k
Danhui Weng China	22	926 1.2×	492 0.9×	471 1.9×	97 0.9×	19 0.2×	41	1.5k
Randall Evans United States	13	609 0.8×	220 0.4×	132 0.5×	83 0.8×	34 0.3×	24	991
Morten Grauslund Denmark	21	848 1.1×	464 0.9×	203 0.8×	45 0.4×	22 0.2×	44	1.4k
Emmanuel T. Akporiaye United States	22	745 1.0×	634 1.2×	193 0.8×	92 0.9×	41 0.4×	51	1.6k
Chao Liang China	20	724 1.0×	336 0.6×	345 1.4×	132 1.2×	17 0.2×	53	1.3k

Countries citing papers authored by Harry A. Rogoff

Since Specialization

Citations

This map shows the geographic impact of Harry A. Rogoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry A. Rogoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry A. Rogoff more than expected).

Fields of papers citing papers by Harry A. Rogoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry A. Rogoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry A. Rogoff. The network helps show where Harry A. Rogoff may publish in the future.

Co-authorship network of co-authors of Harry A. Rogoff

This figure shows the co-authorship network connecting the top 25 collaborators of Harry A. Rogoff. A scholar is included among the top collaborators of Harry A. Rogoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry A. Rogoff. Harry A. Rogoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shah, Manish A. & Harry A. Rogoff. (2021). Implications of reactive oxygen species on cancer formation and its treatment. Seminars in Oncology. 48(3). 238–245. 84 indexed citations

Hsu, Eric J., et al.. (2019). Evaluation of Tumor Cell–Tumor Microenvironment Component Interactions as Potential Predictors of Patient Response to Napabucasin. Molecular Cancer Research. 17(7). 1429–1434. 22 indexed citations

Froeling, Fieke E. M., Astrid Deschênes, Iok In Christine Chio, et al.. (2019). Bioactivation of Napabucasin Triggers Reactive Oxygen Species–Mediated Cancer Cell Death. Clinical Cancer Research. 25(23). 7162–7174. 58 indexed citations

Froeling, Fieke E. M., Iok In Christine Chio, Min Yao, et al.. (2019). Bioactivation of napabucasin triggers reactive oxygen species–mediated cancer cell death. Annals of Oncology. 30. v791–v791. 6 indexed citations

Rogoff, Harry A., et al.. (2017). Abstract LB-023: STK17A, a novel serine threonine kinase, promotes cancer stemness phenotypes by phosphorylating β-catenin. Cancer Research. 77(13_Supplement). LB–23. 1 indexed citations

Chen, Zhu, et al.. (2017). Abstract LB-142: Identification of STK33 as a cancer stemness kinase and regulator of Nanog function. Cancer Research. 77(13_Supplement). LB–142. 1 indexed citations

Rogoff, Harry A., Juying Li, & Chiang Li. (2017). Abstract 4777: Cancer stemness and resistance: Napabucasin (BBI-608) sensitizes stemness-high cancer cells to Paclitaxel by inhibiting the STAT3-MUC1 pathway. Cancer Research. 77(13_Supplement). 4777–4777. 8 indexed citations

Gao, Yuan, Sarah Keates, Eric J. Hsu, et al.. (2016). Abstract 2222: Dual inhibition of cancer stemness and immune checkpoint genes by targeting Stat3. Cancer Research. 76(14_Supplement). 2222–2222. 2 indexed citations

Li, Youzhi, Harry A. Rogoff, Sarah Keates, et al.. (2015). Suppression of cancer relapse and metastasis by inhibiting cancer stemness. Proceedings of the National Academy of Sciences. 112(6). 1839–1844. 382 indexed citations breakdown →

10.

Li, Youzhi, Harry A. Rogoff, Sarah Keates, et al.. (2015). Abstract LB-253: Inhibition of stemness by BBI608 is sufficient to suppress cancer relapse and metastasis. Cancer Research. 75(15_Supplement). LB–253. 1 indexed citations

11.

Langleben, Adrian, Jeffrey G. Supko, Sébastien J. Hotte, et al.. (2013). A dose-escalation phase I study of a first-in-class cancer stemness inhibitor in patients with advanced malignancies.. Journal of Clinical Oncology. 31(15_suppl). 2542–2542. 23 indexed citations

12.

Hong, Sun Woo, Hye Suk Kang, Xiangao Sun, et al.. (2009). Asymmetric Shorter-duplex siRNA Structures Trigger Efficient Gene Silencing With Reduced Nonspecific Effects. Molecular Therapy. 17(4). 725–732. 91 indexed citations

13.

Sun, Xiangao, Harry A. Rogoff, & Chiang J. Li. (2008). Asymmetric RNA duplexes mediate RNA interference in mammalian cells. Nature Biotechnology. 26(12). 1379–1382. 94 indexed citations

14.

Frame, Fiona M., Harry A. Rogoff, Mary Pickering, W. Douglas Cress, & Timothy F. Kowalik. (2006). E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts. Oncogene. 25(23). 3258–3266. 44 indexed citations

15.

Chen, Chang-Rung, et al.. (2005). Dual Induction of Apoptosis and Senescence in Cancer Cells by Chk2 Activation: Checkpoint Activation as a Strategy against Cancer. Cancer Research. 65(14). 6017–6021. 41 indexed citations

16.

Frame, Fiona M., et al.. (2005). Human Cytomegalovirus IE1-72 Activates Ataxia Telangiectasia Mutated Kinase and a p53/p21-Mediated Growth Arrest Response. Journal of Virology. 79(17). 11467–11475. 59 indexed citations

17.

Rogoff, Harry A., Mary Pickering, Fiona M. Frame, et al.. (2004). Apoptosis Associated with Deregulated E2F Activity Is Dependent on E2F1 and Atm/Nbs1/Chk2. Molecular and Cellular Biology. 24(7). 2968–2977. 103 indexed citations

18.

Rogoff, Harry A. & Timothy F. Kowalik. (2004). Life, Death, and E2F: Linking Proliferation Control and DNA Damage Signaling via E2F1. Cell Cycle. 3(7). 843–844. 27 indexed citations

19.

Rogoff, Harry A., Mary Pickering, Michelle Debatis, Stephen N. Jones, & Timothy F. Kowalik. (2002). E2F1 Induces Phosphorylation of p53 That Is Coincident with p53 Accumulation and Apoptosis. Molecular and Cellular Biology. 22(15). 5308–5318. 90 indexed citations

20.

Thomas, Robert J., et al.. (2002). Growth Asymmetry and Auxin Transport in Setae of Gravistimulated Pellia epiphylla Sporophytes. The Bryologist. 105(3). 407–410. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact